Skip to Main Content

Author Details

Steven A Krilis
University of NSW
1979
166
52
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34794103οeta-2-glycoprotein I exerts antithrombotic function through its domain V in mice.J Autoimmun2022
34098405Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.J Autoimmun2021
32938215Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in Atherosclerotic Coronary Artery Disease.Arterioscler Thromb Vasc Biol2020
30685523The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.Thromb Res2019
31069778Quantitation of Total and Free Thiol Angiotensinogen as a Prognostic Marker for Preeclampsia.Methods Mol Biol2019
31069777Quantitation of Total and Free Thiol β<sub>2</sub>-Glycoprotein I Levels for Diagnostic and Prognostic Purposes in the Antiphospholipid Syndrome.Methods Mol Biol2019
29604397Oxidative post-translational modification of βeta 2-glycoprotein I in the pathophysiology of the anti-phospholipid syndrome.Free Radic Biol Med2018
30253188Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration.Free Radic Biol Med2018
28811580οeta 2-glycoprotein I protects mice against gram-negative septicaemia in a sexually dimorphic manner.Sci Rep2017
28193842Experimental Arthritis Is Dependent on Mouse Mast Cell Protease-5.J Biol Chem2017
28159936Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degeneration.Oncotarget2017
29190946β2GPI exerts an anti-obesity effect in female mice by inhibiting lipogenesis and promoting lipolysis.Oncotarget2017
25827171Do Beta 2-Glycoprotein I Disulfide Bonds Protect the Human Retina in the Setting of Age-Related Macular Degeneration?Antioxid Redox Signal2016
27766046Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome.Thromb J2016
27670000Gram Negative Bacterial Inflammation Ameliorated by the Plasma Protein Beta 2-Glycoprotein I.Sci Rep2016
26982501CD117+ Dendritic and Mast Cells Are Dependent on RasGRP4 to Function as Accessory Cells for Optimal Natural Killer Cell-Mediated Responses to Lipopolysaccharide.PLoS One2016
27031114The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injury.PLoS One2016
26312482Improved Assay for Quantifying a Redox Form of Angiotensinogen as a Biomarker for Pre-Eclampsia: A Case-Control Study.PLoS One2015
24692206Deletion of the antiphospholipid syndrome autoantigen β2 -glycoprotein I potentiates the lupus autoimmune phenotype in a Toll-like receptor 7-mediated murine model.Arthritis Rheumatol2014
25696873Laboratory methods to detect antiphospholipid antibodies.Hematology Am Soc Hematol Educ Program2014
24821729Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic obstructive pulmonary disease and colitis.J Biol Chem2014
24507159Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.Adv Immunol2014
24526778In APS, two A1's are better than one!Blood2014
22192282Intracoronary upregulation of platelet extracellular matrix metalloproteinase inducer (CD147) in coronary disease.Int J Cardiol2013
23484830The pathogenesis of the antiphospholipid syndrome.N Engl J Med2013
22240262Post-translational oxidative modification of β2-glycoprotein I and its role in the pathophysiology of the antiphospholipid syndrome.Autoimmun Rev2012
22704541Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis.J Autoimmun2012
22511759Ras guanine nucleotide-releasing protein-4 (RasGRP4) involvement in experimental arthritis and colitis.J Biol Chem2012
20876457Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel.Blood2011
21781264Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.J Thromb Haemost2011
21618459Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.Arthritis Rheum2011
21303837Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies.Lupus2011
21089000New insights into the biology and pathobiology of beta2-glycoprotein I.Curr Rheumatol Rep2011
21173247Essential role for mast cell tryptase in acute experimental colitis.Proc Natl Acad Sci U S A2011
19725764Q fever cholecystitis in an unvaccinated butcher diagnosed by gallbladder polymerase chain reaction.Vector Borne Zoonotic Dis2010
20847215Beta 2 glycoprotein I is a substrate of thiol oxidoreductases.Blood2010
20979592Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1.J Thromb Haemost2010
20551379Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury.Blood2010
20655705In vivo modulation of angiogenesis by beta 2 glycoprotein I.J Autoimmun2010
20346971Risk stratification and outcome of cellulitis admitted to hospital.J Infect2010
18755986How we diagnose the antiphospholipid syndrome.Blood2009
21829418Dapsone hypersensitivity syndrome causing disseminated intravascular coagulation.BMJ Case Rep2009
19587374How I treat the antiphospholipid syndrome.Blood2009
19248095Ro 60 functions as a receptor for beta(2)-glycoprotein I on apoptotic cells.Arthritis Rheum2009
18024961The Diacylglycerol-dependent translocation of ras guanine nucleotide-releasing protein 4 inside a human mast cell line results in substantial phenotypic changes, including expression of interleukin 13 receptor alpha2.J Biol Chem2008
18383370Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2-glycoprotein I autoantibodies.Arthritis Rheum2008
18452581Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain.J Thromb Haemost2008
16985176Current concepts on the pathogenesis of the antiphospholipid syndrome.Blood2007
17265495Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.Arthritis Rheum2007
16144798Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor.Blood2006
  • 1 - 50 of 166

Recommended Authors

Center for Biologics Evaluation and Research
Career Start Year 1996
Number of shared co-authors 0
The University of Cincinnati
Career Start Year 1994
Number of shared co-authors 0
University of Wisconsin School of Medicine and Public Health
Career Start Year 1994
Number of shared co-authors 0
Krembil Research Institute, University Health Network
Career Start Year 1993
Number of shared co-authors 1
Clinical Services
Career Start Year 1991
Number of shared co-authors 0
Center for Biologics Evaluation and Research
Career Start Year 1989
Number of shared co-authors 0
University of Bristol
Career Start Year 1989
Number of shared co-authors 0
Weill Cornell School of Medicine
Career Start Year 1988
Number of shared co-authors 2
Institute of Inflammation and Ageing, University of Birmingham
Career Start Year 1987
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Stony Brook Renaissances School of Medicine, Stony Brook University
Career Start Year 1984
Number of shared co-authors 0
University of Cambridge
Career Start Year 1984
Number of shared co-authors 0
Duke University Medical Center
Career Start Year 1983
Number of shared co-authors 4
University of Otago
Career Start Year 1983
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 1982
Number of shared co-authors 0
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Career Start Year 1982
Number of shared co-authors 0
University of Texas Southwestern Medical Center
Career Start Year 1981
Number of shared co-authors 1
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 0
Biomedical Center, Lund University
Career Start Year 1979
Number of shared co-authors 0
University of California san francisco
Career Start Year 1978
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1977
Number of shared co-authors 0
Haemacon Ltd
Career Start Year 1976
Number of shared co-authors 0
BioKien LLC
Career Start Year 1976
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1974
Number of shared co-authors 0
University of Toronto, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1974
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 0
University of California
Career Start Year 1972
Number of shared co-authors 0
Allergy and Clinical Immunology, University of California at Davis
Career Start Year 1967
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1965
Number of shared co-authors 0
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1958
Number of shared co-authors 0

Collaborators

School of Biomedical Sciences and Pharmacy, University of Newcastle
Co-authored papers 20
Inc. 10555 Stella link
Co-authored papers 16
School of Psychiatry and Clinical Neurosciences, University of Western Australia
Co-authored papers 14
University of New South Wales, The St. George Hospital
Co-authored papers 14
Harvard Medical School
Co-authored papers 12
University of California San Francisco
Co-authored papers 9
Johns Hopkins University School of Medicine
Co-authored papers 9
Concord Repatriation General Hospital
Co-authored papers 9
St George Hospital, University of New South Wales
Co-authored papers 7
La Jolla Pharmaceutical Company
Co-authored papers 5
Co-authored papers 5
Brigham & Women's Hospital
Co-authored papers 5
Indian Institute of Science Education and Research Pune
Co-authored papers 4
Lilly Research Laboratories
Co-authored papers 4
La Jolla Pharmaceutical Company
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
University of New South Wales
Co-authored papers 4
Save Sight Institute, University of Sydney
Co-authored papers 3
Tokyo Medical and Dental University
Co-authored papers 3
Garvan Institute of Medical Research
Co-authored papers 3
Royal Victorian Eye and Ear Hospital, the University of Melbourne
Co-authored papers 3
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 3
Toranomon Hospital
Co-authored papers 2
Co-authored papers 2
School of Pharmacy, East China University of Science and Technology
Co-authored papers 2
Harvard Medical School
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2